Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc.
1:14-cv-00268
Overview
Parties
Defendant
Watson Laboratories Inc. Operating Company
Represented By
6 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Actavis Inc. Operating Company
Represented By
2 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Counter Defendant
Takeda Pharmaceuticals USA Inc. Operating Company
Represented By
8 Attorneys ListedWomble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
Womble Bond Dickinson (US) LLP
1313 North Market Street, Suite 1200
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 17 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7619004
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2008-12-03
Issued: 2009-11-17
|
Active (2.0 yrs remaining)
Expires: 2028-12-03
|
|
|
US7601758
Methods for concomitant administration of colchicine and macrolide antibiotics in the treatment of gout flares
|
Filed: 2009-02-10
Issued: 2009-10-13
|
Active (2.2 yrs remaining)
Expires: 2029-02-10
|
|
|
US7820681
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2009-02-17
Issued: 2010-10-26
|
Active (2.2 yrs remaining)
Expires: 2029-02-17
|
|
|
US7915269
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2010-08-18
Issued: 2011-03-29
|
Active (3.7 yrs remaining)
Expires: 2030-08-18
|
|
|
US8093297
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2011-04-22
Issued: 2012-01-10
|
Active (4.4 yrs remaining)
Expires: 2031-04-22
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
28
Dispositive
1
Granted
2
Denied
0
Pending / Review
24
Motions by Category
Key Dispositive Motions & Rulings